Physician profile
Connie Leanza
NPI 1205921152
$5,935.28
in general payments reported to CMS, 2019-2025
26 companies · $2,000 in 2025
The $2,000 reported for 2025 was more than what 95% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $415 · 2022: $927 · 2023: $1,310 · 2024: $1,283 · 2025: $2,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,582 · Education: $10.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,581.98 |
| Education | $10.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,353.40 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $799.34 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $728.88 | 2021-2025 | Ofev, Jascayd |
| Takeda Pharmaceuticals U.S.A., INC. | $472.00 | 2021-2025 | Glassia |
| Genzyme Corporation | $314.36 | 2021-2025 | |
| Grifols USA, LLC | $312.85 | 2021-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $259.90 | 2021-2024 | Yupelri |
| Harmony Biosciences LLC | $255.50 | 2022-2024 | Wakix |
| Electromed, INC. | $245.50 | 2023-2025 | Smartvest |
| Avadel Cns Pharmaceuticals, LLC | $173.80 | 2023-2025 | Lumryz |
| Baxter Healthcare | $159.98 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System, Hillrom - Monarch Airway Clearance System |
| Verona Pharma, INC. | $159.10 | 2025 | Ohtuvayre |
| Regeneron Healthcare Solutions, INC. | $143.57 | 2024-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $101.42 | 2021-2022 | |
| Insmed, INC. | $85.89 | 2021-2025 | Arikayce |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $71.42 | 2022-2023 | |
| Inspire Medical Systems, INC. | $48.22 | 2024-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $46.97 | 2025 | Opsumit, Uptravi |
| Axsome Therapeutics, INC. | $44.68 | 2024-2025 | Sunosi |
| United Therapeutics Corporation | $34.83 | 2022-2023 | Tyvaso |
| Advanced Respiratory, INC | $31.28 | 2021 | |
| Lilly USA, LLC | $26.67 | 2025 | Zepbound |
| Hikma Pharmaceuticals USA | $17.63 | 2025 | Ryaltris |
| Mallinckrodt Hospital Products INC. | $17.34 | 2025 | Acthar |
| Viatris Specialty LLC | $16.38 | 2025 | Yupelri |
| Idorsia Pharmaceuticals US INC | $14.37 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Leanza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.